MRNA

Moderna Stock Analysis

AI Rating

Low
  • Quality1/10
  • Growth↑ 6/10
  • Value↓ 0/10
Moderna sales and earnings growth
MRNA Growth
Good
  • Revenue Y/Y↓ -31.58%
  • EPS Y/Y↑ 6.64%
  • FCF Y/Y↑ 60.26%
Moderna gross and profit margin trends
MRNA Profitability
Low
  • Gross margin ↑ 22.10%
  • EPS margin↓ -143.60%
  • ROIC 5Y↓ -24.87%
Moderna net debt vs free cash flow
MRNA Risk
Great
  • Debt / Equity↓ 0.2
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Moderna stock volatility is in-line with the overall market. We give it a Great risk rating.

↗ More Biotechnology stocks